A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

UBT251, the triple hormone-receptor agonist developed by United Biotechnology and licensed by Novo Nordisk for treatment of type 2 diabetes and obesity, has achieved good blood sugar-lowering and ...

A blood test could help clinicians identify patients with traumatic brain injury (TBI) who may otherwise go undiagnosed.

An experimental bispecific antibody designed to activate selected populations of T cells has produced early tumor responses in patients with advanced cancers, including some whose disease had resisted ...